for-phone-onlyfor-tablet-portrait-upfor-tablet-landscape-upfor-desktop-upfor-wide-desktop-up

Aurora Cannabis Inc

ACB.N

Latest Trade

2.43USD

Change

-0.01(-0.41%)

Volume

2,124,405

Today's Range

2.42

 - 

2.45

52 Week Range

2.14

 - 

10.31

As of on the Toronto Stock Exchange ∙ Minimum 15 minute delay

Pricing

Previous Close
2.44
Open
2.43
Volume
2,124,405
3M AVG Volume
176.42
Today's High
2.45
Today's Low
2.42
52 Week High
10.31
52 Week Low
2.14
Shares Out (MIL)
1,050.54
Market Cap (MIL)
3,372.24
Forward P/E
-18.79
Dividend (Yield %)
--

Next Event

Q2 2020 Aurora Cannabis Inc Earnings Release

Latest Developments

More

Aurora Cannabis And CTT Pharmaceutical Announce Launch Of Sublingual Cannabis Wafers

Aurora Cannabis Inc - Intends To Develop New Products Under New Brand, Roar Sports

Aurora Cannabis Announces Financial Results For The Fourth Quarter

for-phone-onlyfor-tablet-portrait-upfor-tablet-landscape-upfor-desktop-upfor-wide-desktop-up

About Aurora Cannabis Inc

Aurora Cannabis Inc is a Canada-based medical cannabis company. Through its subsidiaries, the Company manages two operating segments plus Corporate: Medical Cannabis, Horizontally Integrated Businesses and Other. The Medical Cannabis segment produces and distributes medical cannabis in Canada and distributes it via wholesale in the European Union. Additionally, it includes the production and sale of indoor cultivation systems and hemp related food products. The Company’s production capacity is of over 625,000 kilograms per year.

Industry

Biotechnology & Drugs

Contact Info

500-10355 Jasper Ave NW

+1.604.3625207

https://www.auroramj.com

Executive Leadership

Michael Singer

Executive Chairman of the Board

Steve Dobler

President, Director

Terry Booth

Chief Executive Officer, Director

Glen Ibbott

Chief Financial Officer

Allan Cleiren

Chief Operational Officer

Key Stats

2.53 mean rating - 17 analysts
Sell
Hold
Buy
Revenue (MM, CAD)

2017

0.0K

2018

0.1K

2019

0.2K

2020(E)

0.4K
EPS (CAD)

2017

-0.040

2018

-0.240

2019

-0.290

2020(E)

-0.161
Price To Earnings (TTM)
--
Price To Sales (TTM)
11.49
Price To Book (MRQ)
0.74
Price To Cash Flow (TTM)
--
Total Debt To Equity (MRQ)
17.82
LT Debt To Equity (MRQ)
11.67
Return on Investment (TTM)
-7.84
Return on Equity (TTM)
-7.42

Latest News

Latest News

Aurora Cannabis pushes back profitability target to fiscal 2020

Canadian company Aurora Cannabis Inc <ACB.TO> pushed back its profitability timeline to fiscal 2020 on Wednesday after missing its earlier target of the fourth quarter, blaming the slow roll-out of retail outlets for recreational marijuana.

Aurora Cannabis quarterly revenue surges

Aurora Cannabis Inc reported a surge in revenue on Wednesday, as demand got a boost from Canada's legalization of recreational marijuana use late last year.

Aurora Cannabis wins contract to supply medical cannabis to Italy

Canadian pot producer Aurora Cannabis Inc said on Thursday it had secured a two-year contract to supply medical cannabis to the Italian government.

Aurora Cannabis wins contract to supply medical cannabis to Italy

Canadian pot producer Aurora Cannabis Inc said on Thursday it had secured a two-year contract to supply medical cannabis to the Italian government.

Tilray, Aurora Cannabis sales jump after Canada legalizes recreational marijuana

Cannabis producers Tilray Inc and Aurora Cannabis Inc on Tuesday reported a surge in quarterly revenue, boosted by increased demand following the legalization of recreational cannabis in Canada.

Cannabis maker Aurora picks billionaire investor Peltz as adviser

Canada's Aurora Cannabis Inc on Wednesday tapped billionaire Nelson Peltz as a strategic adviser, betting on the consumer industry-focused veteran to help the recreational marijuana maker chart its expansion into new markets.

Cannabis maker Aurora picks billionaire investor Nelson Peltz as adviser

Canada's Aurora Cannabis Inc said on Wednesday it had picked billionaire investor Nelson Peltz as a strategic advisor.

Canadian pot producer Aurora Cannabis beats revenue estimates

Aurora Cannabis Inc reported a better-than-expected quarterly revenue on Monday, as the company benefited from higher sales after Canada legalized the use of recreational cannabis in October.

Canadian pot producer Aurora Cannabis' quarterly revenue surges

Aurora Cannabis Inc reported a sharp jump in quarterly revenue on Monday, as the company benefited from higher sales after Canada legalised the use of recreational cannabis in October.

Aurora Cannabis to supply medical marijuana to Mexico

Canada's Aurora Cannabis Inc said on Friday it has partnered with privately held pharmaceutical manufacturer and distributer Farmacias Magistrales SA to supply medical cannabis to Mexico.

Aurora Cannabis production plant gets sales license

Aurora Cannabis Inc said on Wednesday its Aurora Sky production plant was granted a sales license by Canada's health regulator as the country becomes the second in the world to legalize recreational marijuana.

Aurora Cannabis plans U.S. stock listing in October

Canada's Aurora Cannabis Inc <ACB.TO> said on Thursday it planned a U.S. listing of its shares in October, as it looks to cash in on strong investor appetite for marijuana producers.

Aurora Cannabis targeting October for U.S. stock listing - Financial Post

Canada's Aurora Cannabis Inc is looking to list its shares in the U.S. in October, the Financial Post reported on Wednesday, citing one of its executives.

Aurora says no deal with beverage makers for weed-based drinks

Aurora Cannabis Inc said on Tuesday it had not partnered with any beverage company, responding to a media report that Coca-Cola Co was in talks with the Canadian weed producer to make marijuana infused drinks.

Coke, Aurora in talks for cannabis-infused drinks -BNN Bloomberg

Coca-Cola Co is in talks with Canadian marijuana producer Aurora Cannabis Inc to make cannabis-infused beverages, BNN Bloomberg reported on Monday.

BRIEF-Aurora Cannabis Makes Strategic Investment In CTT Pharmaceutical

* AURORA CANNABIS MAKES STRATEGIC INVESTMENT IN CTT PHARMACEUTICAL Source text for Eikon: Further company coverage:

BRIEF-Aurora Cannabis Says Targeting August To Close The Deal - Conf Call

* AURORA CANNABIS CEO SAYS WILL FOCUS ON ACQUISITIONS THAT HELP GAIN ACCESS TO NEW REGIONS - CONF CALL

Aurora to buy MedReleaf for $2.5 billion in biggest ever pot deal

Aurora Cannabis Inc will buy rival MedReleaf Corp for C$3.2 billion ($2.51 billion) in the biggest deal yet to unify major Canadian pot growers, as the country moves toward legalizing marijuana for recreational use.

BRIEF-Aurora Cannabis To Acquire MedReleaf in C$3.2 Bln Deal

* AURORA CANNABIS INC - HOLDERS OF MEDRELEAF COMMON SHARES WILL RECEIVE 3.575 COMMON SHARES OF AURORA FOR EACH MEDRELEAF COMMON SHARE HELD

Aurora Cannabis to buy rival MedReleaf in C$3.2 bln deal

Medical marijuana maker Aurora Cannabis Inc said on Monday it would buy rival MedReleaf Corp in a deal valued at C$3.2 billion ($2.51 billion).

Quote and financial data from Refinitiv. Fund performance data provided by Lipper. All quotes delayed a minimum of 15 minutes.

for-phone-onlyfor-tablet-portrait-upfor-tablet-landscape-upfor-desktop-upfor-wide-desktop-up